Paracetamol and metabolite pharmacokinetics in infants

被引:58
作者
van der Marel, CD
Anderson, BJ
van Lingen, RA
Holford, NHG
Pluim, MAL
Jansman, FGA
van den Anker, JN
Tibboel, D
机构
[1] Erasmus MC Sophia, Intens Care Unit Pediat Surg, NL-3015 GJ Rotterdam, Netherlands
[2] Erasmus MC Sophia, Dept Paediat Surg, Rotterdam, Netherlands
[3] Erasmus MC Sophia, Dept Pharm, Rotterdam, Netherlands
[4] Erasmus MC Sophia, Dept Paediat, Rotterdam, Netherlands
[5] Univ Hosp Maastricht, Dept Anaesthesia, Maastricht, Netherlands
[6] Isala Clin Zwolle, Dept Paediat, Zwolle, Netherlands
[7] Isala Clin Zwolle, Dept Pharm, Zwolle, Netherlands
[8] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
[9] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol, Washington, DC 20010 USA
[10] George Washington Univ, Med Ctr, Dept Pediat & Pharmacol, Washington, DC 20037 USA
关键词
paracetamol; metabolism; infants;
D O I
10.1007/s00228-003-0608-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background. Data concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates (<6 weeks) or children (3-9 years). There are no studies investigating infants. Methods. Infants (n=47) undergoing major craniofacial surgery were given paracetamol 19-45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33-59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models. Results. Mean (+/-SD) age and weight of the patients were 11.8+/-2.5 months and 9.1+/-1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric '1/4 power' models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0.55 (28) l/h/70 kg. The urine clearance of unchanged paracetamol and metabolites was related to urine volume flow rate. Clearance attributable to pathways other than these measured in urine was not identifiable. The glucuronide/sulphate formation clearance ratio was 0.69 at 12 months of age. Sulphate metabolism contributed 50% towards paracetamol clearance. Conclusion. Glucuronide formation clearance increases with age in the infant age range but sulphate formation does not. Renal clearance of paracetamol and its metabolites increases with urine flow rate. This and other studies show that paracetamol metabolism to glucuronide appears to be similar in infants and children, but in adults is increased in comparison with children. Oxidative pathways were undetectable in this infant study and may explain, in part, the reduced incidence of hepatotoxicity in infants.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 43 条
[1]   AGE-RELATED DIFFERENCES IN SALICYLAMIDE AND ACETAMINOPHEN CONJUGATION IN MAN [J].
ALAM, SN ;
ROBERTS, RJ ;
FISCHER, LJ .
JOURNAL OF PEDIATRICS, 1977, 90 (01) :130-135
[2]   ASSAY OF PARACETAMOL AND ITS METABOLITES IN URINE, PLASMA AND SALIVA OF CHILDREN WITH CHRONIC LIVER-DISEASE [J].
ALOBAIDY, SS ;
PO, ALW ;
MCKIERNAN, PJ ;
GLASGOW, JFT ;
MILLERSHIP, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (08) :1033-1039
[3]   A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children [J].
Anderson, BJ ;
Woollard, GA ;
Holford, NHG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (02) :125-134
[4]   Acetaminophen developmental pharmacokinetics in premature neonates and infants - A pooled population analysis [J].
Anderson, BJ ;
van Lingen, RA ;
Hansen, TG ;
Lin, YC ;
Holford, NHG .
ANESTHESIOLOGY, 2002, 96 (06) :1336-1345
[5]   Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients [J].
Anderson, BJ ;
McKee, AD ;
Holford, NHG .
CLINICAL PHARMACOKINETICS, 1997, 33 (05) :313-327
[6]   THE EFFECT OF PROPRANOLOL ON PARACETAMOL METABOLISM IN MAN [J].
BARAKA, OZ ;
TRUMAN, CA ;
FORD, JM ;
ROBERTS, CJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (02) :261-264
[7]   EFFECT OF VASOPRESSIN ON REABSORPTION OF PHENACETIN AND ITS METABOLITES FROM TUBULAR FLUID IN MAN [J].
BARRACLOUGH, MA .
CLINICAL SCIENCE, 1972, 43 (05) :709-+
[8]  
Beal SL, 1999, NONMEM USERS GUIDE
[9]   Current issues in mutagenesis and carcinogenesis .65. The genotoxicity and carcinogenicity of paracetamol: A regulatory [J].
Bergman, K ;
Muller, L ;
Teigen, SW .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1996, 349 (02) :263-288
[10]  
Conner, 1983, ECOLOGICAL IMPLICATI, P48, DOI 10.1017/CBO9780511608551